Patents Assigned to Common Services Agency
-
Patent number: 9677051Abstract: This invention provides method and media suitable for inducing and supporting the differentiation of stem cells into erythroid cells.Type: GrantFiled: July 18, 2013Date of Patent: June 13, 2017Assignees: The Common Services Agency, University Court of the University of GlasgowInventors: Joanne Mountford, Emmanuel Oliver
-
Publication number: 20130164733Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: ApplicationFiled: July 13, 2012Publication date: June 27, 2013Applicant: Common Services AgencyInventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
-
Patent number: 8398987Abstract: The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerization.Type: GrantFiled: January 18, 2008Date of Patent: March 19, 2013Assignees: The University Court of the University of Aberdeen, The Common Services Agency for the Scottish Health ServiceInventors: Stanislaw Joseph Urbaniak, Robert Norman Barker, Hosea Sukati
-
Publication number: 20130045544Abstract: The present invention related to an improved method for the detection of prion proteins, especially abnormal prion proteins (PrPSc), in samples of blood, such as plasma. The invention also relates to kits for use in such methods.Type: ApplicationFiled: May 3, 2011Publication date: February 21, 2013Applicant: Common Services AgencyInventor: Michael Jones
-
Patent number: 8318421Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: GrantFiled: July 11, 2011Date of Patent: November 27, 2012Assignee: Common Services AgencyInventors: Peter Simmonds, Shiu-Wan Chan, Peng Lee Yap
-
Publication number: 20110287410Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: ApplicationFiled: July 11, 2011Publication date: November 24, 2011Applicant: Common Services AgencyInventors: Peter Simmonds, Shiu-Wan Chan, Peng Lee Yap
-
Patent number: 7976849Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: GrantFiled: March 19, 2010Date of Patent: July 12, 2011Assignee: Common Services AgencyInventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
-
Publication number: 20100266624Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: ApplicationFiled: March 19, 2010Publication date: October 21, 2010Applicant: Common Services AgencyInventors: Peter Simmonds, Shiu-Wan Chan, Peng Lee Yap
-
Patent number: 7709006Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: GrantFiled: January 12, 2007Date of Patent: May 4, 2010Assignee: Common Services AgencyInventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
-
Publication number: 20100086562Abstract: The present invention relates to a composition for treating diseases associated with autoantibodies specific for platelet proteins, in particular autoimmune thrombocytopenic purpura. The composition, comprising an epitope of a platelet protein, treats diseases by tolerisation.Type: ApplicationFiled: January 18, 2008Publication date: April 8, 2010Applicants: THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN, THE COMMONS SERVICES AGENCY FOR THE SCOTTISH HEALTInventors: Stanislaw Joseph Urbaniak, Robert Norman Barker, Hosea Sukati
-
Patent number: 7402315Abstract: The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.Type: GrantFiled: February 20, 2007Date of Patent: July 22, 2008Assignees: Common Services Agency, Murex Diagnostics LimitedInventors: Peter Simmonds, Peng L. Yap, Ian H. Pike
-
Patent number: 7252720Abstract: Prion infectivity adsorbed onto substrates (for example, chromatographic columns used to fractionate blood plasma) is removed by treatment with 2M sodium chloride. Optionally, the substrate is further washed with 0.1 M sodium hydroxide.Type: GrantFiled: May 30, 2003Date of Patent: August 7, 2007Assignee: Common Services AgencyInventors: Peter Reynolds Foster, Brenda Doreen Griffin, Ronald Vance McIntosh
-
Publication number: 20070160630Abstract: The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.Type: ApplicationFiled: February 20, 2007Publication date: July 12, 2007Applicants: Murex Diagnostics International, Inc., Common Services AgencyInventors: Peter Simmonds, Peng Yap, Ian Pike
-
Publication number: 20070128221Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: ApplicationFiled: January 12, 2007Publication date: June 7, 2007Applicant: Common Services AgencyInventors: Peter Simmonds, Shui-Wan Chan, Peng Yap
-
Patent number: 7198892Abstract: The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.Type: GrantFiled: March 25, 2005Date of Patent: April 3, 2007Assignee: Common Services AgencyInventors: Peter Simmonds, Peng Lee Yap, Ian Hugo Pike
-
Patent number: 7179470Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: GrantFiled: March 25, 2003Date of Patent: February 20, 2007Assignee: Common Services AgencyInventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
-
Publication number: 20050221296Abstract: The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.Type: ApplicationFiled: March 25, 2005Publication date: October 6, 2005Applicants: Murex Diagnostics International, Inc., Common Services AgencyInventors: Peter Simmonds, Peng Yap, Ian Pike
-
Patent number: 6881821Abstract: Newly elucidated sequences of hepatitis C virus type 4 and type 5 are described, together with those of a newly discovered type 6. Unique type-specific sequences in the NS4, NS5 and core regions enable HCV detection and genotyping into types 1 to 6. Antigenic peptides and immunoassays are described.Type: GrantFiled: May 5, 1994Date of Patent: April 19, 2005Assignees: Common Services Agency, Murex Diagnostics International Inc.Inventors: Peter Simmonds, Peng Lee Yap, Ian Hugo Pike
-
Publication number: 20030198946Abstract: New styles of hepatitis C virus (HCV), referred to as HCV-3 and HCV-4, have been identified and sequenced. Antigenic regions of HCV-2, HCV-3 and HCV-4 polypeptides have been identified. Immunoassays for HCV and antibodies thereto are described, which allow more complete screening of blood samples for HCV, and allow HCV genotyping.Type: ApplicationFiled: March 25, 2003Publication date: October 23, 2003Applicant: COMMON SERVICES AGENCYInventors: Peter Simmonds, Shui-Wan Chan, Peng Lee Yap
-
Patent number: 6485932Abstract: Liquid compositions for intravenous administration that comprise an aqueous solution of immunoglobulin and methods of preparing such compositions are disclosed. The solution has a pH in the range of 5.0 to 5.8 and an ionic strength is the range 0.02 to 0.25. The liquid compositions are formulated so as to be stable upon storage such that the immunoglobulin does not substantially aggregate nor degrade and maintains acceptable levels of anti-complementary activity, PKA activity and kallikrein activity during storage for an extended period at a temperature in the range of 4° C. to 25° C.Type: GrantFiled: October 25, 1999Date of Patent: November 26, 2002Assignee: Common Services AgencyInventors: Ronald Vance McIntosh, Anne Gillian Welch